Table 2. Experimental conditions.
| Protein/peptide | Cell/beam-line |
|---|---|
| Reduced RNase | Flow/APS/BioCAT |
| Snase | Flow/APS/BESSRC-CAT |
| α-TS | Static/SSRL/4-2 |
| Creatine kinase | Flow/APS/BESSRC-CAT |
| GCN4-p2′ | Flow/APS/BioCAT |
| OspA | Flow/SSRL/4-2 |
| ctAcP | Flow/APS/BioCAT |
| Ubiquitin | Flow/APS/BioCAT |
| Fyn SH3 | Flow/APS/BESSRC-CAT |
| pI3K SH3 | Static/SSRL/4-2 |
| pI3K SH2 | Static/SSRL/4-2 |
| N-terminal cytochrome c | Flow/APS/BESSRC-CAT |
| AK-37 | Flow/APS/BESSRC-CAT |
| AK-32 | Flow/APS/BESSRC-CAT |
| AK-27 | Flow/APS/BESSRC-CAT |
| AK-16 | Flow/APS/BESSRC-CAT |
| Angiotensin | Flow/APS/BESSRC-CAT |
APS, Advanced Photon Source; SSRL, Stanford Synchrotron Radiation Laboratory.